Literature DB >> 8093358

Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host.

T Aebischer1, S F Moody, E Handman.   

Abstract

The persistence of Leishmania major parasites in mice resistant to infection was investigated by the polymerase chain reaction and in vitro culture methods. Parasite-specific DNA was detected in the lymph nodes, spleens, bone marrow, and livers of C57BL/6 mice 1 year after their recovery from infection. Live parasites were also recovered from these tissues (except liver tissues) and were used to establish in vitro isolates. Pulsed-field gel electrophoresis, Southern blotting, and Western blot (immunoblot) analyses showed that these isolates retained the karyotype and the phenotype of the original inoculum, including the levels of expression of gp63 and lipophosphoglycan, the two major surface molecules of Leishmania species. More importantly, these isolates were virulent and induced fatal disease when injected into susceptible BALB/c mice. Persistence was shown to be a more general phenomenon, since several different strains of mice which were resistant to L. major infection also harbored persistent parasites. The implications for the etiology of human leishmaniasis in immunocompromised individuals such as AIDS patients are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8093358      PMCID: PMC302708          DOI: 10.1128/iai.61.1.220-226.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  The promastigote surface protease of Leishmania.

Authors:  C Bordier
Journal:  Parasitol Today       Date:  1987-05

2.  Leishmania major and L. donovani: a method for rapid purification of amastigotes.

Authors:  T A Glaser; S J Wells; T W Spithill; J M Pettitt; D C Humphris; A J Mukkada
Journal:  Exp Parasitol       Date:  1990-10       Impact factor: 2.011

3.  A note on concomitant immunity in host-parasite relationships: a successfully transplanted concept from tumor immunology.

Authors:  G F Mitchell
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

4.  A model for the mechanism of sensitivity of BALB/c mice to L. major and premunition in leishmaniasis.

Authors:  F Modabber
Journal:  Ann Inst Pasteur Immunol       Date:  1987 Sep-Oct

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 6.  The present and future of vaccination for cutaneous leishmaniasis.

Authors:  C L Greenblatt
Journal:  Prog Clin Biol Res       Date:  1980

7.  An overview of the problem of toxoplasmosis and pneumocystosis in AIDS in the USA: implication for future therapeutic trials.

Authors:  B J Luft; K G Castro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

8.  Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients.

Authors:  C Meller-Melloul; C Farnarier; S Dunan; B Faugere; J Franck; C Mary; P Bongrand; M Quilici; S Kaplanski
Journal:  Parasite Immunol       Date:  1991-09       Impact factor: 2.280

9.  Systemic infection of Leishmania tropica (major) in various strains of mice.

Authors:  C Leclerc; F Modabber; E Deriaud; L Cheddid
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

10.  Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products.

Authors:  N E Reiner; W Ng; W R McMaster
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

View more
  43 in total

1.  Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major.

Authors:  R Lira; M Doherty; G Modi; D Sacks
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.

Authors:  Chahnaz Kébaïer; Jude E Uzonna; Stephen M Beverley; Phillip Scott
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 4.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 5.  Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.

Authors:  H Moll; U Ritter; S Flohé; K Erb; C Bauer; C Blank
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

6.  The PCR-based detection of Leishmania major in Mus musculus and other rodents caught in southern Iran: a guide to sample selection.

Authors:  M Parhizkari; M H Motazedian; Q Asqari; D Mehrabani
Journal:  Ann Trop Med Parasitol       Date:  2011-06

7.  Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

8.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

9.  Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.

Authors:  E Handman; F M Symons; T M Baldwin; J M Curtis; J P Scheerlinck
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Experimental murine paracoccidioidomycosis: relationship among the dissemination of the infection, humoral and cellular immune responses.

Authors:  L M Singer-Vermes; C B Caldeira; E Burger; L G Calich
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.